Article Information
History
- March 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- María Tristán-Manzano1,*,
- Noelia Maldonado-Pérez1,*,
- Pedro Justicia-Lirio1,2,
- Pilar Muñoz1,
- Marina Cortijo-Gutiérrez1,
- Kristina Pavlovic1,3,
- Rosario Jiménez-Moreno3,
- Sonia Nogueras3,
- MDolores Carmona3,
- Sabina Sánchez-Hernández1,
- Araceli Aguilar-González1,4,
- María Castella5,
- Manel Juan5,
- Concepción Marañón1,
- Karim Benabdellah1,
- Concha Herrera3 and
- Francisco Martin1,#
- 1Department of Genomic Medicine, Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research (GENYO), PTS, Avda. de la Ilustración 114, 18016 Granada, Spain
- 2LentiStem Biotech, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO), PTS, Avda. de la Ilustración 114, 18016 Granada, Spain
- 3Maimonides Institute of Biomedical Research in Córdoba (IMIBIC), Cellular Therapy Unit, Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain
- 4Department of Medicinal and Organic Chemistry, Faculty of Pharmacy, University of Granada, Campus Cartuja, 18071 Granada, Spain
- 5Department of Hematology, ICMHO, Hospital Clínic de Barcelona, Villarroel 170, 08036 Barcelona, Spain
- ↵#Corresponding author: Francisco Martin., Gene and Cell therapy Unit, Department of Genomic Medicine, Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research (GENYO), PTS, Avda. de la Ilustración 114, 18016 Granada, Spain., francisco.martin{at}genyo.es